Trial Profile
Safety and efficacy of Ginkgo biloba extract EGb-761 in patients with mild cognitive impairment
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary)
- Indications Mild cognitive impairment
- Focus Adverse reactions; Therapeutic Use
- Sponsors Dr. Willmar Schwabe Group
- 07 Oct 2015 New trial record